ARGX
ARGENX SE - ADR
Health Care·Biotechnology·NETHERLANDS
$1,033.15
MCap $64.2B
as of 2026-09-04
Total
A3w
Fund
A5w
Quant
A3w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.57
Sentiment 83.1%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$1,033.15
Adaptive Mean
$1,060.16
-27.01 vs mean
Adaptive σ
23.49
MIDOS BB
$1,013.18 – $1,107.13
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.14
ROE
23.6%
Z +0.59
Rev Gr
59.3%
Z +0.28
EPS Gr
95.2%
Z —
OPM Gr
11.1%
Z +0.41
FCF Yld
1.2%
Z +0.17
EPS Surp
0.2%
Z -0.53
EPS 3mo Δ
45.1%
Z -0.10
Fwd P/E
26.28
Z —
PEGY
0.28
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
8.56
Q6M
10.08
Q12M
5.58
MA 30/100
1.081
Bullish (MA30 > MA100)
α (Jensen)
0.6910
β (12M)
0.32
σ (12M)
0.347
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
73%
Q Percentile
82%
Divergence
-9.4
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
24.8
RS Pctl
85%
RS Decile
D9
Persistence
3w
at grade A
Options / OI Analysis
No options or Williams data available for this ticker.